Today: 7 February 2026
Subscribe
Browse Category

Financial Updates News 8 December 2025 - 10 December 2025

Hindustan Unilever Share Price Today (10 December 2025): HUL Stock Turns Oversold After Kwality Wall’s Demerger

Hindustan Unilever Share Price Today (10 December 2025): HUL Stock Turns Oversold After Kwality Wall’s Demerger

Mumbai | 10 December 2025 Hindustan Unilever Limited (HUL), one of India’s most widely owned FMCG stocks, is going through a classic “great company, tricky stock” phase. On 10 December 2025, Hindustan Unilever share price was hovering around ₹2,300 on the NSE, down about 0.2% intraday and roughly 12–13% lower over the last three months.The Economic Times+1 The stock has slipped enough for its 14-day Relative Strength Index (RSI) to fall below 30, putting HUL in the “oversold” zone for the first time in many months.Business Standard The weakness comes just days after the demerger of Kwality Wall’s India, HUL’s
10 December 2025
····
Vodafone Idea Share Price Near 52-Week High: AGR Relief Hopes, Fundraising and Tariff Buzz Fuel Rally

Vodafone Idea Share Price Near 52-Week High: AGR Relief Hopes, Fundraising and Tariff Buzz Fuel Rally

Vodafone Idea Ltd (NSE: IDEA, BSE: 532822) is back in the spotlight on 10 December 2025 as its share price hovers just below a fresh 52-week high, backed by heavy trading volumes, improving quarterly numbers and renewed optimism around regulatory relief on long‑standing adjusted gross revenue (AGR) dues. As of early afternoon on 10 December, the stock was trading around ₹10.8–10.9 per share, after hitting an intraday high of ₹11.07 – only a tick below its 52‑week peak of ₹11.08 touched in mid‑November. Over the past six months, Vodafone Idea has delivered a gain of roughly 55%, lifting its market
10 December 2025
······
Meesho Share Price Today: 46% Listing Premium, ₹200 Target and What the Blockbuster IPO Means for Investors

Meesho Share Price Today: 46% Listing Premium, ₹200 Target and What the Blockbuster IPO Means for Investors

On 10 December 2025, Meesho Limited (NSE: MEESHO) made one of the most closely watched stock market debuts of the year, listing at around ₹162 per share against an IPO price of ₹111, a premium of roughly 46% on both NSE and BSE. Intraday, the stock surged further towards the ₹172–177 range, valuing the company at about ₹77,000 crore on listing day. Free Press Journal+3Samco+3Business Standard+3 By early afternoon on listing day, Meesho was trading around ₹170 per share on NSE, about 53% higher than the issue price and roughly 5% above its listing level, with a one‑day traded value
10 December 2025
······
ASX Biggest Losers Today: Cogstate, Immuron and GQG Partners Lead Australian Stock Market Declines (10 December 2025)

ASX Biggest Losers Today: Cogstate, Immuron and GQG Partners Lead Australian Stock Market Declines (10 December 2025)

Updated Wednesday, 10 December 2025 – mid‑session (approx. 2:00pm AEDT) The Australian share market is treading water today, but beneath the flat S&P/ASX 200 headline, a cluster of healthcare, speculative miners and financials are taking heavy hits. While gold stocks and other resources names are propping up the index, stocks like Cogstate, Immuron, GQG Partners and a raft of micro‑caps feature prominently on the “biggest losers” board.Market Index Below is a look at today’s biggest percentage losers on the ASX, why they’re under pressure, and what recent forecasts and analysis say about their outlooks. Market overview: Flat index hides sharp
10 December 2025
········
Crypto Stocks Today: Coinbase and Bitcoin Miners Climb as Wall Street Closes (December 9, 2025)

Crypto Stocks Today: Coinbase and Bitcoin Miners Climb as Wall Street Closes (December 9, 2025)

Coinbase edges higher while key Bitcoin mining stocks stage a broad rebound, even as a new Tether‑backed crypto stock slumps on debut and traders brace for a crucial Fed decision. Key Takeaways Market Snapshot: Crypto Stocks Into the Close U.S. equities finished mixed but little changed on Tuesday as traders digested President Donald Trump’s approval of limited Nvidia H200 chip sales to China and the start of a two‑day Federal Reserve policy meeting. The Dow slipped roughly 0.3%, the Nasdaq added about 0.1%, and the S&P 500 drifted around flat in late trade. Investopedia In digital assets, Bitcoin spent the
9 December 2025
····
Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Published: December 9, 2025 Arcellx, Inc. (NASDAQ: ACLX) has jumped back onto Wall Street’s radar after releasing highly positive Phase 2 data for its multiple myeloma cell therapy anitocabtagene autoleucel (“anito-cel”) at the American Society of Hematology (ASH) 2025 meeting. The new data have driven a sharp move in the stock, a flurry of analyst updates, and renewed debate about valuation ahead of a planned 2026 commercial launch. Where Arcellx Stock Stands Today As of the close on December 9, 2025, Arcellx shares traded at $72.08, down about 2.7% on the day after a strong pre-market surge earlier in the
9 December 2025
·····
UK Stock Market Today (9 December 2025): FTSE 100 Edges Higher as Defence Stocks Offset BAT Slide

UK Stock Market Today (9 December 2025): FTSE 100 Edges Higher as Defence Stocks Offset BAT Slide

The UK stock market spent Tuesday moving in a narrow band but ultimately closed modestly higher, as defence stocks helped the FTSE 100 overcome weakness in tobacco and consumer names ahead of crucial interest rate decisions from the US Federal Reserve and the Bank of England. Market snapshot: modest gains for FTSE 100 and FTSE 250 By early afternoon in London, the FTSE 100 was up around 0.1%, with the domestically focused FTSE 250 gaining about 0.2%, helped by strong defence shares and despite pressure on British American Tobacco (BAT). Reuters+1 Later price data show the blue‑chip FTSE 100 finished the
9 December 2025
····
Dyne Therapeutics (DYN) Stock Slides After $300 Million Offering as Duchenne Trial Data Drives Bullish Street Targets

Dyne Therapeutics (DYN) Stock Slides After $300 Million Offering as Duchenne Trial Data Drives Bullish Street Targets

December 9, 2025 — Dyne Therapeutics, Inc. (NASDAQ: DYN) shares were volatile on Tuesday, giving back part of a recent rally even as Wall Street responded positively to new clinical data and raised price targets on the neuromuscular‑disease biotech. In early afternoon U.S. trading, Dyne stock was changing hands around $19.15, down roughly 14% on the day after opening near $21.41 and moving in a range between about $19 and $22. The pullback follows a sharp advance on Monday, when the shares jumped high‑single‑digits after the company released detailed positive Phase 1/2 results from its DELIVER trial in Duchenne muscular
9 December 2025
·····
Tesla Stock (TSLA) Today: Morgan Stanley Downgrade, China Sales Twist and 2026 AI Bet – December 9, 2025

Tesla Stock (TSLA) Today: Morgan Stanley Downgrade, China Sales Twist and 2026 AI Bet – December 9, 2025

Tesla, Inc. (NASDAQ: TSLA) is back in the spotlight as Wall Street recalibrates its expectations for the world’s most valuable automaker‑turned‑AI company. As of midday Tuesday, December 9, 2025, Tesla shares trade around $439.58, giving the company a market capitalization of roughly $1.46 trillion.MarketBeat The stock is up single digits this year after a volatile run and sits about 10% below last year’s record high.Investopedia Yet that price implies a price‑to‑earnings ratio near 300 and a PEG multiple above 15, levels that leave very little room for error.MarketBeat+1 That stretched valuation is exactly why Tesla just got hit with a
9 December 2025
·····
ASX Top Gainers Today: Immutep, Cosmo Metals, OD6 & Sunrise Energy Metals Lead the Rally (9 December 2025)

ASX Top Gainers Today: Immutep, Cosmo Metals, OD6 & Sunrise Energy Metals Lead the Rally (9 December 2025)

Despite a flat headline index, Australia’s share market is serving up double‑digit moves in small-cap resources, lithium and biotech stocks today. Market snapshot: quiet ASX 200, loud movers underneath The S&P/ASX 200 spent Tuesday morning drifting slightly lower, extending a pattern of tight trading ranges as investors waited on the Reserve Bank of Australia’s final interest rate decision for 2025. By late morning, the benchmark was down around 0.1%–0.2%, with breadth skewed to the downside and weakness in energy, gold and parts of tech offset by pockets of strength in resources and healthcare. Market Index+1 Markets are largely positioned for
9 December 2025
·······
India Stock Market Today: 10 Things To Know Before the Opening Bell on 9 December 2025

India Stock Market Today: 10 Things To Know Before the Opening Bell on 9 December 2025

Indian equities head into Tuesday’s session on the back foot. After a broad-based sell-off on Monday and fresh record weakness in the rupee, early indicators point to a cautious to negative start for the Nifty 50 and Sensex on 9 December 2025. As of around 2:45 a.m. IST, GIFT Nifty futures were hovering near 25,950, down about 0.3–0.4%, signalling a weak opening for the cash market. gopocket.in At the same time, global markets are treading water ahead of a closely watched U.S. Federal Reserve meeting, while domestic sentiment is digesting the RBI’s 25 bps repo rate cut to 5.25%, a new F&O pre-open session, and stock-specific
8 December 2025
····
W.R. Berkley (WRB) Stock: Mitsui Stake, $1 Special Dividend and 2026 Outlook After 14% Pullback

W.R. Berkley (WRB) Stock: Mitsui Stake, $1 Special Dividend and 2026 Outlook After 14% Pullback

Published: December 8, 2025 – all data and forecasts cited are as of this date. WRB stock today: price, performance and volatility W.R. Berkley Corporation (NYSE: WRB) shares are trading around $66.77 on Monday, December 8, 2025. That’s only slightly up on the day, but it comes after a sharp sell‑off. Over the last week, the stock has dropped about 14%, and it’s still down roughly 10–11% over the past month. FinanceCharts+1 Despite the recent slide, WRB is up about 15% year to date and roughly 5% over the last 12 months. The stock hit a 52‑week high of $78.96
8 December 2025
····
1 … 35 36 37 38 39 … 47

Stock Market Today

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

Northern Star Resources share price dips into weekend as $50m Central Tanami deal closes

7 February 2026
Northern Star Resources fell 1.7% to A$26.77 Friday, extending losses as gold miners and the broader market declined. MGX Resources completed its A$50 million purchase of a 50% stake in the Central Tanami Gold Project from Northern Star. The All Ordinaries Gold index dropped 3.24%. CME Group raised COMEX gold futures margin requirements to 9% amid volatility.
PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

PLS Group share price slips into weekend as Morgan Stanley and MUFG filings land

7 February 2026
PLS Group shares closed at A$4.12 Friday, down 1.2% after a 3.7% drop Thursday. Morgan Stanley and Mitsubishi UFJ Financial Group disclosed increased voting power in the lithium miner, both citing changes dated Feb. 2. The moves came as lithium prices fell and Australian equities posted their sharpest drop in months. PLS reports interim results Feb. 19.
Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

Commonwealth Bank share price near A$159 as CBA earnings, dividend week looms after ASX rout

7 February 2026
Commonwealth Bank of Australia shares closed at A$158.91, down 0.23% Friday, as the S&P/ASX 200 fell 2.03% and nearly A$70 billion was wiped from the market. The bank reports half-year results and an interim dividend on Feb. 11, with shares going ex-dividend Feb. 18. CBA flagged a A$68 million provision linked to ASIC’s Better Banking review. The RBA raised rates to 3.85% on Feb. 3, with CBA passing on the increase from Feb. 13.
Go toTop